Navigation Links
New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma Leads to Increased Costs
Date:11/15/2010

Among the two groups of patients there was no significant difference in their use of acute asthma medications, emergency room visits or hospitalizations, indicating that there was no apparent additional clinical benefit gained from using the combined therapy compared to ICS monotherapy.  However, the study did find a difference in costs:  the average asthma-related health care costs for those using the combination ICS/LABA therapy were $264 higher per patient per year than those using the ICS treatment alone.  The study included all combination ICS/LABA drugs, confirming that this is a class effect rather than attributed to a single product.

Findings also revealed that the rate of ICS/LABA combination therapy was highest among patients ages 18 to 49.

In 2010, the Food & Drug Administration (FDA) updated the label on long-acting beta agonists to specify that they should not be used in patients with well-controlled asthma. In patients where a LABA is necessary, once asthma control is achieved and maintained, patients should begin step-down therapy that eliminates the use of long-acting beta agonist while continuing on their ICS treatment.  Lastly, it states that long-acting beta agonists should only be used as additional therapy for patients with uncontrolled asthma currently taking an ICS.

Mild Persistent Asthma

Asthma severity can be classified into one of the following four categories:  intermittent, mild persistent, moderate persistent or severe persistent. Characteristics of a patient classified with mild persistent asthma in this study are:

  • Claims-confirmed diagnosis of asthma and lack of COPD (chronic obstructive pulmonary disease) diagnosis
  • In the previous 12 months:
    • Sporadic use of reliever medications (less than 4 canisters)
    • No exacerbation requiring hospital or ER visits
  • '/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
2. New Study: Pine Bark Significantly Reduces Menstrual Pain
3. New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
4. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
5. New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
8. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
9. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
10. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
11. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 With advancements in neurological ... market is seeing new growth, according to Kalorama ... account for the majority of market volume, newer ... images, which are creating opportunities for more sophisticated applications. ... growing at a rate of 4%, with world ...
(Date:12/17/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or ... of $125 million aggregate principal amount of 3.75% Convertible ... offered and sold only to qualified institutional buyers pursuant ... as amended (the "Securities Act"). The Notes ... year, payable semiannually in arrears on June 15 and ...
(Date:12/15/2014)... 15, 2014 Registreer nu via  ... und 20. Februar sind alle akkreditierten pharmazeutischen ... ECOSYSTEM PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, der ... die neue profitablen Unternehmensdienstleistungen, die für Apotheken ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... implement advanced patient outcome analysis software to monitor health ... Global Health Research Foundation (GHRF) today ... the Westly Foundation to fund asthma treatment in California,s ... asthma cases in the state. The grant will help ...
... February 4 Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a ... it has concluded a proof of concept,study in ... technology. Eight healthy volunteers came for two visits, ... The insulin suppositories showed rapid insulin absorption and ...
Cached Medicine Technology:Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in California's Central Valley 2Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2
(Date:12/17/2014)... A group of 127 scientists sent an ... reaction to a recent statement by the center that was ... derogated the efficacy of all brain exercises. , Signatories to ... of the center’s statement critical of brain exercise companies that ... overstated its case, in a document it had entitled “A ...
(Date:12/17/2014)... 2014 (HealthDay News) -- As gas prices rose in ... new study suggests. In times of gas increases, ... riders are inexperienced, the researchers explained. They examined ... has the highest number of motorcycle registrations in the ... deaths. The analysis revealed a strong association between ...
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. ... fast approaching, a new study reveals that states that routinely ... drunk drivers on their roads. The finding suggests that ... able to deter inebriated revelers from getting behind the wheel ... being passed regarding drinking and driving," said study lead author ...
(Date:12/15/2014)... CITY, NV (PRWEB) December 15, 2014 ... powerhouse company, JM Ocean Avenue. JM Ocean Avenue ... of the Veretekk online automated marketing system. JM ... the June 2014 merger of Ocean Avenue and JM ... more than $2 Billion per year company. , “After ...
(Date:12/15/2014)... December 15, 2014 Health Dialog, ... announced today that it has received Patient Oriented ... (NCQA) for its Disease Management (DM) Programs for ... (COPD), coronary heart disease and diabetes. This marks ... for Health Dialog’s Disease Management (DM) Programs, reaffirming ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2
... leader in,providing do-it-yourself market research, and Funky Monkey ... released the,results of a client sponsored online survey ... their recommended daily dose of fruit., According ... consumption,include spoilage (47%), need for preparation (28%), stickiness ...
... MATEO, Calif., Dec. 5 BioForm Medical,Inc. (Nasdaq: ... it will,report its September 30, 2007 first quarter fiscal ... press release after the NASDAQ,Global Market closes and will ... Time (5:30 p.m. Eastern Time)., BioForm Chief Executive ...
... on http://www.thepill.com , RARITAN, N.J., Dec. 5 ... do Modern Girls really know about this birth,control choice?, ... http://www.prnewswire.com/mnr/ortho/29291/ , Since its development more than 45 years ... control method. Although more than 80 percent,of American women have ...
... Donates "Asthma & Allergy Friendly" Toys to Kids ... Dec. 5 The oldest and largest,allergy patient ... Allergy,Foundation of America (AAFA), made the holidays a ... to asthma, allergies or,other respiratory diseases by donating ...
... media attention, bi-coastal ... distribution underway, PORTLAND, Maine, Dec. ... new line of all-natural simmer sauces for,chicken. The new sauces -- ... Foods markets throughout the north Atlantic (MA,ME, RI) and northeast regions ...
... HSKA ) today announced it will present at the ... Conference on,December 11, 2007 at 1177 Avenue of the ... York, NY. The presentation is scheduled to begin,at 2:10 ... be available,via live webcast and for two weeks following ...
Cached Medicine News:Health News:Why Fruit Gets Short Shrift in U.S. Diet: Online Poll 2Health News:BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007 2Health News:Video: What 'Modern Girls' Should Know About the Pill 2Health News:Video: What 'Modern Girls' Should Know About the Pill 3Health News:Allergy Foundation Thinks Globally, Gifts Locally 2Health News:Good Clean Food's New Line of All-Natural Simmer Sauces for Chicken Hits Market Shelves 2Health News:Good Clean Food's New Line of All-Natural Simmer Sauces for Chicken Hits Market Shelves 3
... a medical device designed to handle the ... and archiving demands of the EEG laboratory. ... that helps organize workflow and the collection, ... database and powerful search capability keeps track ...
... The P3000 heralds a new concept in pupillometry, ... infrared optical system developed for the P2000. ... in which we have paid particular attention to ... Our new system is extremely flexible, allowing you ...
...
... Peg electrodes typically are ... to enable epidural recording of ... contacts and are furnished in ... skull thicknesses. A 4.6 mm ...
Medicine Products: